Zeffix is indicated for the treatment of chronic hepatitis B in adults
with:
compensated liver disease with evidence of active viral replication,
persistently elevated serum alanine aminotransferase (ALT) levels and
histological evidence of active liver inflammation and / or fibrosis.
decompensated liver disease.
Posology and
method of administration
Therapy should be initiated by a physician experienced in the
management of chronic hepatitis B.
The recommended dosage of Zeffix is 100 mg once daily. Zeffix can be
taken with or without food.